Drugs / IC47
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00873431 | Mar 2009 → Feb 2010 | pneumococcal infection | Valneva Austria GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IC47 | “Biological: IC47” NCT00873431 ↗ |
| Modality | Vaccine | “a New Vaccine Against Streptococcus Pneumoniae” NCT00873431 ↗ |
| Route | Intramuscular | “solution/suspension for i.m. injection” NCT00873431 ↗ |